Goldman Sachs Maintains Buy Rating on Intuitive Surgical Amid Bearish Sentiment
Despite a broader bearish trend among Wall Street analysts, Goldman Sachs has maintained its 'Buy' rating and raised price target for Intuitive Surgical (ISRG), which has seen its stock fall about 28% in 2026. The firm argues that recent concerns over reusable surgical tools are misplaced.
